BLPH

Bellerophon Therapeutics (PK) (BLPH)

Bellerophon Therapeutics Inc (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:BLPH

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/05	07 : 25	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2024/03/02	00 : 04	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2024/02/13	05 : 44	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2024/02/13	02 : 39	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2023/12/13	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2023/11/15	06 : 31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2023/11/07	06 : 30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2020/02/08	02 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2020/01/30	06 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2020/01/28	06 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2020/01/07	22 : 22	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2019/12/27	22 : 26	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2019/12/17	22 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2019/11/26	06 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2019/11/20	06 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2019/11/20	06 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2019/11/20	06 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2019/11/20	06 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
2019/11/20	06 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)